BR112012028315A2 - "composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença". - Google Patents

"composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença".

Info

Publication number
BR112012028315A2
BR112012028315A2 BR112012028315A BR112012028315A BR112012028315A2 BR 112012028315 A2 BR112012028315 A2 BR 112012028315A2 BR 112012028315 A BR112012028315 A BR 112012028315A BR 112012028315 A BR112012028315 A BR 112012028315A BR 112012028315 A2 BR112012028315 A2 BR 112012028315A2
Authority
BR
Brazil
Prior art keywords
oral
preventing
spray
inhibitor
reducing
Prior art date
Application number
BR112012028315A
Other languages
English (en)
Inventor
Bradley M Mitteness
Connie Phillips
Original Assignee
Camas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camas Inc filed Critical Camas Inc
Publication of BR112012028315A2 publication Critical patent/BR112012028315A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença. um inibidor de aderência microbiana na forma de anticorpos de ovo de ave doméstica é revelado, juntamente com o método de sua preparação e métodos de seu uso. o inibidor funciona substancialmente pela prevenção da fixação da aderência de imunógenes formadores de colônias dentro dos tratos respiratórios de animais e humanos hospedeiros. o inibidor é preparado por inoculação de aves fêmeas com o imunógeno, colheita dos ovos que contêm anticorpos para o imunógeno, e separação da gema e da albumina das cascas dos ovos. os conteúdos gema e albumina são administrados aos animais ou a humano pela distribuição dos conteúdos diretamente ou pela introdução dos conteúdos arrastados em ar. o material inibidor de aderência pode ser formulado para uso em uma variedade de maneiras tal como um borrifo oral ou um borrifo nasal. estas formulações podem ser efetivas para prevenir ou reduzir doenças respiratórias em animais e humanos.
BR112012028315A 2010-05-07 2011-05-09 "composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença". BR112012028315A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33242110P 2010-05-07 2010-05-07
PCT/US2011/035739 WO2011140550A2 (en) 2010-05-07 2011-05-09 Immunogen adherence and method of making and using same

Publications (1)

Publication Number Publication Date
BR112012028315A2 true BR112012028315A2 (pt) 2016-10-25

Family

ID=44902084

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012028315A BR112012028315A2 (pt) 2010-05-07 2011-05-09 "composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença".

Country Status (9)

Country Link
US (2) US20110274701A1 (pt)
EP (1) EP2566521A4 (pt)
CN (1) CN102933232A (pt)
AU (1) AU2011249882A1 (pt)
BR (1) BR112012028315A2 (pt)
CA (1) CA2798151A1 (pt)
MX (1) MX2012012915A (pt)
WO (1) WO2011140550A2 (pt)
ZA (1) ZA201209198B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9701737B2 (en) 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
MX2012012915A (es) * 2010-05-07 2013-05-06 Camas Inc Adherencia de inmunogeno y metodo para formar y utilizar el mismo.
CA2905375A1 (en) 2013-03-15 2014-09-18 Camas Incorporated Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
US11168127B1 (en) * 2015-12-01 2021-11-09 Camas Incorporated Pathogen specific avian antibodies in the neonatal mammal
MX2019014943A (es) * 2018-12-12 2020-08-06 Cambridge Tech Llc Vacuna universal contra la gripe.
AU2021267035A1 (en) * 2020-05-08 2023-01-05 Camas Incorporated Reduction of viral disease transmission by avian antibodies
JP2023545851A (ja) * 2020-10-19 2023-10-31 カマス インコーポレイテッド 感染性疾患の伝播を減少させるために受動免疫を使用する方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166867A (en) 1978-02-09 1979-09-04 Ralston Purina Company Palatability in horse feeds
US4550019A (en) 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5753268A (en) 1982-06-03 1998-05-19 Dcv Biologics, L.P. Anti-cholesterolemic egg, vaccine and method for production, and use
GB8405530D0 (en) 1984-03-02 1984-04-04 Lysons R J Vaccine for swine dysentery
CA1306946C (en) 1985-11-25 1992-09-01 Hideo Tokoro Specific antibody-containing substance from eggs and method of production and use thereof
JPS62175426A (ja) * 1986-01-27 1987-08-01 Kazufumi Shimizu 抗体及びこれを有効成分とするスプレ−剤
US5196193A (en) 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
US5556744A (en) 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US6337070B1 (en) 1993-04-29 2002-01-08 Takara Shuzo Co., Ltd. Polypeptides for use in generating anti-human influenza virus antibodies
US5367054A (en) 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
US6068862A (en) 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
US5420253A (en) * 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
US6156726A (en) * 1996-08-02 2000-12-05 Elan Pharmaceuticals, Inc. Voltage-gated calcium channel antagonist and method
US6086878A (en) 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
US20020012666A1 (en) * 1998-11-05 2002-01-31 Hellen Chaya Greenblatt A method for increasing weight gain and feed efficiency
US7241443B1 (en) 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
FR2810550B1 (fr) * 2000-06-27 2004-10-08 Medibrevex Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication
WO2002018239A1 (en) * 2000-08-28 2002-03-07 Traylor Keith J Snap-on sprayer assembly for spraying sweetened compositions
CN1819844B (zh) * 2003-02-19 2012-02-22 彼得·纳什 免疫原粘附抑制剂及其制备和使用方法
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
EP1758554A1 (en) * 2004-06-12 2007-03-07 Passion For Life Healthcare Limited Soluble strip for oral or topical adminstration
EP1930346B1 (en) * 2005-08-29 2011-10-19 Japan Science and Technology Agency Antibody produced using ostrich and method for production thereof
CN1958608B (zh) * 2005-10-31 2012-07-04 深圳雅臣生物科技有限公司 抗禽流感特异性IgY的制备方法及其制剂
US20110166328A1 (en) * 2008-09-02 2011-07-07 Huan Nguyen Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
MX2012012915A (es) * 2010-05-07 2013-05-06 Camas Inc Adherencia de inmunogeno y metodo para formar y utilizar el mismo.

Also Published As

Publication number Publication date
AU2011249882A1 (en) 2013-01-10
EP2566521A4 (en) 2013-11-27
US20130183286A1 (en) 2013-07-18
WO2011140550A3 (en) 2012-03-08
MX2012012915A (es) 2013-05-06
WO2011140550A2 (en) 2011-11-10
US9849175B2 (en) 2017-12-26
US20110274701A1 (en) 2011-11-10
EP2566521A2 (en) 2013-03-13
ZA201209198B (en) 2013-08-28
CN102933232A (zh) 2013-02-13
CA2798151A1 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
BR112012028315A2 (pt) "composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença".
Fallah et al. Effect of dietary inclusion of turmeric and thyme powders on performance, blood parameters and immune system of broiler chickens.
Landy et al. Performance, carcass characteristics, and immunity in broiler chickens fed dietary neem (Azadirachta indica) as alternative for an antibiotic growth promoter
Greger The human/animal interface: emergence and resurgence of zoonotic infectious diseases
Allameh et al. Effect of dietary valine supplementation to low protein diets on performance, intestinal morphology and immune responses in broiler chickens
Alahgholi et al. Effect of betaine as an osmolyte on broiler chickens exposed to different levels of water salinity
BR112014011443A2 (pt) bactérias do ácido láctico e seu uso como suplementos alimentares para aves domésticas
HK1087949A1 (en) Immunogene adherence and method of making and using the same
Sumanu et al. Effect of probiotic and fisetin supplementation on performance, carcass characteristics and small intestinal morphology in broiler chickens
Akanbi et al. Comparative study on diphtheritic, cutaneous and systemic forms of natural avipoxvirus infection in chickens
Taha et al. Growth performance and immune response against Newcastle and avian influenza vaccines in Egyptian chicken strains
EP3019524B1 (en) Canine health product containing antibodies against canine parvovirus type 2
Bulus et al. Effect of garlic extract on immunological response of broiler and FUNAAB-ALPHA breed of chicken in comparison to Newcastle disease vaccine (Lasota).
RU2568906C1 (ru) Способ лечения паразитарных болезней сельскохозяйственных и плотоядных животных
Bentley Toward the control of veterinary viruses of food production animals
JP6483263B2 (ja) 鶏の健康状態の向上による生産性向上のための飼料要求率改善用および死亡・淘汰率改善用剤
Miljević et al. Ehinokokoza-tranutno stanje u Srbiji-prirodni rezervoari
Akinlade et al. ECONOMIC IMPACT OF COVID-19: OPPORTUNITIES IN BROILER PRODUCTION FOR NIGERIANS
Petrović et al. Detekcija i tipizacija koronavirusa kod slepih miševa u Srbiji
RU2471503C1 (ru) Способ борьбы с эктопаразитами птиц
BR102020023942A2 (pt) Soluções filmogênicas para profilaxia de afecções podais em ruminantes
Chitty Gamebirds
Suteky et al. Ethnoveterinary technology for parasite dewormer to support goat-oil palm integration in Bengkulu Indonesia.
Halsey Salmonella typhimurium infection in broilers and its effects on gastrointestinal health and performance
Shridhar et al. Commercial cattle feed induced dermatitis in bovines

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)